71. Sanders CE, Julian BA, Gaston RS, Deierhoi MH, Diethelm AG, Curtis JJ: Benefits of continued cyclosporine through an indigent drug program. Am J Kidney Dis 28:572–577, 1996.
72. Lagnado, L. Transplant patients ply an illicit market for vital medicines. Wall Street Journal, 6/21/99, p. 1.
The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
"Appendix D: Immunosuppressive Therapy: The Scientific Basis and Clinical Practice of Immunosuppressive Therapy in the Management of Transplant Recipients."
Extending Medicare Coverage for Preventive and Other Services.
Washington, DC: The National Academies Press, 2000.
Please select a format: